Deutsche Bank
FNCH

Deutsche Bank’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Deutsche Bank’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-137
Closed -$21K – 4412
2022
Q1 		$21K Sell
137
-16
-10% -$3.69K ﹤0.01% 4056
2021
Q4 		$46K Buy
153
+8
+6% +$3.07K ﹤0.01% 3977
2021
Q3 		$57K Sell
145
-5
-3% -$2.13K ﹤0.01% 4084
2021
Q2 		$63K Buy
+150
New +$64.9K ﹤0.01% 4259

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Deutsche Bank's FNCH Position: Q2 2022 in Review

Deutsche Bank sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2022, closing a stake of 137 shares — an estimated $21K sold.

Deutsche Bank first reported a position in FNCH in Q2 2021 and held it in 4 quarters. The position peaked at $63K in Q2 2021. 46 funds tracked by Wall St. Rank hold FNCH as of Q2 2022.

  • Deutsche Bank reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 137 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2022, an estimated $21K.
  • Deutsche Bank first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Deutsche Bank's Finch Therapeutics Group, Inc. Common Stock position peaked at $63K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.